Recomendaciones del VIII Consenso Clínico de SIBEN para la Displasia Broncopulmonar

Abstract

Dr Sola has disclosed that he is the Vice President of Medical Affairs with Masimo Corporation. Drs Fariña and Mir have disclosed no financial relationships relevant to the article. Dr Golombek has disclosed that he is on the speakers' bureau with Mallinckrodt and a consultant with Prolacta. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device. El Dr Sola es VP de Medical Affairs de Masimo Corporation. Los Dres. Fariña y Mir declaran ausencia de conflicto de interés. El Dr Golombek pertenece al Speakers' Bureau de Mallinckrodt, y es Consultor de Prolacta. Este artículo no contiene una discusión sobre el uso no aprobado / investigativo de un producto / dispositivo comercial. En este Consenso participaron 48 profesionales de 12 países de Latinoamérica y España. La coordinación y revisión estuvo a cargo de los investigadores principales Dres. Fariña, Mir y Sola quienes han condensado todo el material trabajado. Los participantes del Consenso por orden alfabético fueron:

CCHD Screening Implementation Efforts in Latin American Countries by the Ibero American Society of Neonatology (SIBEN)

“…In addition, a neonatal clinical examination does not detect 20% or more of critical CHD and the observation of cyanosis is not effective in detecting hypoxemia. The Clinical Consensus of SIBEN [ 20 , 21 ] and various other publications (some quoted in this manuscript) clearly show that POS is a simple, low cost, and effective intervention for the early detection of serious neonatal hypoxemic diseases, in addition to CCHD.…”

“…To date, SIBEN has completed 12 consensuses on different clinical topics. The ninth Clinical Consensus was on POS [ 21 ], including the participation of 45 neonatologists and neonatal RNs from 16 countries in the region who worked collaboratively during one year via the internet. Subsequently, the consensus group met in SIBEN’s annual congress in Asunción, Paraguay, where the consensus statement on POS was developed and finalized.…”

“…The Clinical Consensus of SIBEN on POS for neonatal hypoxemic conditions [ 21 ] has been very useful and shows that a fetal ultrasound, even in good hands, has a low sensitivity. Furthermore, it is costly and is lacking or not always available in many regions of Argentina.…”

“…In particular, one was the nursing staff’s lack of information on the subject. Therefore, training began using a step-by-step approach to follow the program as described in SIBEN’s Clinical Consensus [ 21 ]. This took approximately 2–3 months before moving on to the first clinical steps for the early detection of hypoxemic diseases with POS.…”

“…Based on the landmark articles by de-Wahl Granelli [ 7 , 8 , 9 ], Ewer [ 10 , 11 , 12 , 13 , 14 ], Martin and Hom [ 15 , 16 ], Sola [ 17 , 18 , 19 , 20 ], and others, it has become clear that infant safety and outcomes can be improved by assessing oxygenation with adequate saturation monitoring. Back in 2016, we published the results of the “IX SIBEN Consensus on early detection of diseases that course with neonatal hypoxemia using pulse oximetry” [ 21 ], which is a document developed by neonatologists and nurses from Latin America, with the expert opinion of Dr. Andrew Ewer. We formulated recommendations to implement programs with pulse oximetry for the early detection of pathologies and/or diseases that have neonatal hypoxemia in asymptomatic and apparently healthy newborns.…”